Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

P‐26 New aspects of canine demodicosis and the possibility of treatment with selamectin

Identifieur interne : 008A44 ( Main/Exploration ); précédent : 008A43; suivant : 008A45

P‐26 New aspects of canine demodicosis and the possibility of treatment with selamectin

Auteurs : N. Tarpataki [Hongrie] ; E. Kadocsa [Hongrie] ; K. Vörös [Hongrie]

Source :

RBID : ISTEX:A518ECEC8FD485893D5AB37BB8F3560B2BB4DF31

Abstract

The purpose of this study was to evaluate 55 clinical cases of canine demodicosis and to compare the results of treatment using amitraz (solution), selamectin (spot‐on), ivermectin (injection) and cythioate (oral tablets). Data from the 55 cases was collected and evaluated after clinical and microbiological examination. Treatment was selected depending on the severity of demodicosis and compliance of the owner. The cases were followed for 12 months and the status of the patients was grouped on two levels: recovered (58%), or relapsed (42%). Five dogs (9%) were euthanized. The disease was commonly diagnosed in purebred dogs. Demodicosis was more common in dogs under 2 years of age (65%), in males (64%), and in the short‐haired breeds (75%). Demodicosis was generalized in 73% of cases, localised in 23% and affected the feet (pododemodicosis) in 4% of cases. Recovery was the highest in dogs between 1 and 2 years of age (73%), and in the localized cases (92%). Nonspecific treatment with glucocorticoids prior to the diagnosis lowered the rate of recovery (4%), but treatment with glucocorticoids for proven atopic dermatitis improved the rate of recovery (41%). All drugs (amitraz, selamectin, cythioate) administered for the localized form were effective (100% recovered). Recovery in generalized demodicosis was 60% using ivermectin, 55% using amitraz, 44% with the combination of amitraz and selamectin (two treatments with amitraz followed by selamectin), and 43% in cases where selamectin was used alone. Funding: Pfizer Animal Health.

Url:
DOI: 10.1111/j.1365-3164.2004.00414_26.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">P‐26 New aspects of canine demodicosis and the possibility of treatment with selamectin</title>
<author>
<name sortKey="Tarpataki, N" sort="Tarpataki, N" uniqKey="Tarpataki N" first="N." last="Tarpataki">N. Tarpataki</name>
</author>
<author>
<name sortKey="Kadocsa, E" sort="Kadocsa, E" uniqKey="Kadocsa E" first="E." last="Kadocsa">E. Kadocsa</name>
</author>
<author>
<name sortKey="Voros, K" sort="Voros, K" uniqKey="Voros K" first="K." last="Vörös">K. Vörös</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A518ECEC8FD485893D5AB37BB8F3560B2BB4DF31</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.1365-3164.2004.00414_26.x</idno>
<idno type="url">https://api.istex.fr/document/A518ECEC8FD485893D5AB37BB8F3560B2BB4DF31/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">004D64</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004D64</idno>
<idno type="wicri:Area/Istex/Curation">004D64</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F30</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F30</idno>
<idno type="wicri:doubleKey">0959-4493:2004:Tarpataki N:p:new:aspects</idno>
<idno type="wicri:Area/Main/Merge">008D10</idno>
<idno type="wicri:Area/Main/Curation">008A44</idno>
<idno type="wicri:Area/Main/Exploration">008A44</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">P‐26 
New aspects of canine demodicosis and the possibility of treatment with selamectin</title>
<author>
<name sortKey="Tarpataki, N" sort="Tarpataki, N" uniqKey="Tarpataki N" first="N." last="Tarpataki">N. Tarpataki</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Hongrie</country>
<wicri:regionArea>Faculty of Veterinary Sciences, Szent István University, Budapest</wicri:regionArea>
<placeName>
<settlement type="city">Budapest</settlement>
<region nuts="2">Hongrie centrale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kadocsa, E" sort="Kadocsa, E" uniqKey="Kadocsa E" first="E." last="Kadocsa">E. Kadocsa</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Hongrie</country>
<wicri:regionArea>Faculty of Veterinary Sciences, Szent István University, Budapest</wicri:regionArea>
<placeName>
<settlement type="city">Budapest</settlement>
<region nuts="2">Hongrie centrale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Voros, K" sort="Voros, K" uniqKey="Voros K" first="K." last="Vörös">K. Vörös</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Hongrie</country>
<wicri:regionArea>Faculty of Veterinary Sciences, Szent István University, Budapest</wicri:regionArea>
<placeName>
<settlement type="city">Budapest</settlement>
<region nuts="2">Hongrie centrale</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Veterinary Dermatology</title>
<title level="j" type="alt">VETERINARY DERMATOLOGY</title>
<idno type="ISSN">0959-4493</idno>
<idno type="eISSN">1365-3164</idno>
<imprint>
<biblScope unit="vol">15</biblScope>
<biblScope unit="page" from="49">49</biblScope>
<biblScope unit="page" to="49">49</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-08">2004-08</date>
</imprint>
<idno type="ISSN">0959-4493</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0959-4493</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The purpose of this study was to evaluate 55 clinical cases of canine demodicosis and to compare the results of treatment using amitraz (solution), selamectin (spot‐on), ivermectin (injection) and cythioate (oral tablets). Data from the 55 cases was collected and evaluated after clinical and microbiological examination. Treatment was selected depending on the severity of demodicosis and compliance of the owner. The cases were followed for 12 months and the status of the patients was grouped on two levels: recovered (58%), or relapsed (42%). Five dogs (9%) were euthanized. The disease was commonly diagnosed in purebred dogs. Demodicosis was more common in dogs under 2 years of age (65%), in males (64%), and in the short‐haired breeds (75%). Demodicosis was generalized in 73% of cases, localised in 23% and affected the feet (pododemodicosis) in 4% of cases. Recovery was the highest in dogs between 1 and 2 years of age (73%), and in the localized cases (92%). Nonspecific treatment with glucocorticoids prior to the diagnosis lowered the rate of recovery (4%), but treatment with glucocorticoids for proven atopic dermatitis improved the rate of recovery (41%). All drugs (amitraz, selamectin, cythioate) administered for the localized form were effective (100% recovered). Recovery in generalized demodicosis was 60% using ivermectin, 55% using amitraz, 44% with the combination of amitraz and selamectin (two treatments with amitraz followed by selamectin), and 43% in cases where selamectin was used alone. Funding: Pfizer Animal Health.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Hongrie</li>
</country>
<region>
<li>Hongrie centrale</li>
</region>
<settlement>
<li>Budapest</li>
</settlement>
</list>
<tree>
<country name="Hongrie">
<region name="Hongrie centrale">
<name sortKey="Tarpataki, N" sort="Tarpataki, N" uniqKey="Tarpataki N" first="N." last="Tarpataki">N. Tarpataki</name>
</region>
<name sortKey="Kadocsa, E" sort="Kadocsa, E" uniqKey="Kadocsa E" first="E." last="Kadocsa">E. Kadocsa</name>
<name sortKey="Voros, K" sort="Voros, K" uniqKey="Voros K" first="K." last="Vörös">K. Vörös</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008A44 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008A44 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A518ECEC8FD485893D5AB37BB8F3560B2BB4DF31
   |texte=   P‐26 New aspects of canine demodicosis and the possibility of treatment with selamectin
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024